{
    "eid": "2-s2.0-85127961004",
    "title": "COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron",
    "cover-date": "2022-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "breakthrough",
        "inactivated virus",
        "infection",
        "omicron",
        "SARS-CoV-2"
    ],
    "authors": [
        "Nungruthai Suntronwong",
        "Ritthideach Yorsaeng",
        "Jiratchaya Puenpa",
        "Chompoonut Auphimai",
        "Thanunrat Thongmee",
        "Preeyaporn Vichaiwattana",
        "Sitthichai Kanokudom",
        "Thaneeya Duangchinda",
        "Warangkana Chantima",
        "Pattarakul Pakchotanon",
        "Suvichada Assawakosri",
        "Pornjarim Nilyanimit",
        "Sirapa Klinfueng",
        "Lakkhana Wongsrisang",
        "Donchida Srimuan",
        "Thaksaporn Thatsanatorn",
        "Natthinee Sudhinaraset",
        "Nasamon Wanlapakorn",
        "Yong Poovorawan"
    ],
    "citedby-count": 11,
    "ref-count": 19,
    "ref-list": [
        "Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine",
        "Covid-19 breakthrough infections in vaccinated health care workers",
        "Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults",
        "Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost",
        "Third BNT162b2 Vaccination Neutralization of SARS-CoV-2 Omicron Infection",
        "Heterologous immunization with inactivated vaccine followed by mRNA booster elicits strong humoral and cellular immune responses against the SARS-CoV-2 Omicron variant",
        "Neutralizing Activities against the Omicron Variant after a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "Antibody response and variant cross-neutralization after SARS-CoV-2 breakthrough infection",
        "mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection",
        "Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa",
        "SARS-CoV-2 B. 1.1. 529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals",
        "S glycoprotein diversity of the Omicron variant"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "127614853",
            "affilname": "The Royal Society of Thailand (FRS(T))",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127614853",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University",
        "National Research Council of Thailand",
        "Health Systems Research Institute",
        "National Center for Genetic Engineering and Biotechnology"
    ]
}